Failure to Assess Clinical Appropriateness for Self-Administration of Medications
Summary
The facility failed to ensure that self-administration of medications was clinically appropriate for four residents who had medications kept at their bedsides or available for self-use. The report states that the facility policy required an interdisciplinary determination of clinical appropriateness and a nursing assessment of each resident’s mental and physical ability, including understanding labels, knowing the purpose and dosage, removing and ingesting the medication, and recognizing risks and adverse consequences. For the four residents reviewed, the record did not show that these requirements were completed before the medications were left available for self-administration. Resident #1 had diagnoses including hemiplegia/hemiparesis following cerebral infarction, aphasia, acute respiratory failure, COPD, and atrial fibrillation, and was moderately cognitively impaired with a BIMS score of 10. A container of Voltaren was observed on the bedside table on multiple occasions, and the resident said his wife assisted him with the cream when needed. The care plan and self-administration assessment documented only Biotene and fluticasone, and the record did not show an assessment or physician order for Voltaren at the time it was observed at the bedside. Resident #40 had COPD and was cognitively intact with a BIMS score of 13, but an albuterol inhaler and Ayr nasal gel were observed on the bedside table and within reach. The record did not reveal a self-administration care plan, physician order, or assessment for either medication at the time they were observed. Resident #28 had arthritis, type 2 diabetes, hypertension, edema, and pulmonary disease, was moderately cognitively impaired with a BIMS score of 12, and had saline nasal spray and Ayr nasal gel on the bedside table; the record did not show a care plan, physician order, or assessment for those medications. Resident #15 had a femur fracture and hypertension, was moderately cognitively impaired with a BIMS score of 11, and had AlgaeCal on the bedside table; the care plan and physician order were incomplete, and the assessment was not completed until after the concern was identified during the survey.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.